Cite
HARVARD Citation
Bame, E. et al. (2021). Next‐generation Bruton's tyrosine kinase inhibitor BIIB091 selectively and potently inhibits B cell and Fc receptor signaling and downstream functions in B cells and myeloid cells. Clinical & translational immunology. 10 (6), p. n/a. [Online].